Connect Biopharma Holdings Limited (CNTB)

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $136.78 million. The enterprise value is $91.16 million.

Market Cap	136.78M
Enterprise Value	91.16M

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

CNTB has 56.52 million shares outstanding. The number of shares has increased by 1.24% in one year.

Current Share Class	56.52M
Shares Outstanding	56.52M
Shares Change (YoY)	+1.24%
Shares Change (QoQ)	+0.85%
Owned by Insiders (%)	18.57%
Owned by Institutions (%)	18.88%
Float	12.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	585.83
Forward PS	n/a
PB Ratio	3.53
P/TBV Ratio	3.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	391.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.02.

Current Ratio	3.23
Quick Ratio	2.70
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -102.94% and return on invested capital (ROIC) is -65.11%.

Return on Equity (ROE)	-102.94%
Return on Assets (ROA)	-54.20%
Return on Invested Capital (ROIC)	-65.11%
Return on Capital Employed (ROCE)	-153.96%
Weighted Average Cost of Capital (WACC)	3.23%
Revenue Per Employee	$3,641
Profits Per Employee	-$1.01M
Employee Count	64
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, CNTB has paid $191,000 in taxes.

Income Tax	191,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-0.18
52-Week Price Change	n/a
50-Day Moving Average	2.66
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.72
Average Volume (20 Days)	158,552

Short Selling Information

The latest short interest is 1.13 million, so 2.99% of the outstanding shares have been sold short.

Short Interest	1.13M
Short Previous Month	994,618
Short % of Shares Out	2.99%
Short % of Float	n/a
Short Ratio (days to cover)	2.75

Income Statement

In the last 12 months, CNTB had revenue of $233,000 and -$64.61 million in losses. Loss per share was -$1.15.

Revenue	233,000
Gross Profit	233,000
Operating Income	-66.23M
Pretax Income	-64.42M
Net Income	-64.61M
EBITDA	-65.54M
EBIT	-66.23M
Loss Per Share	-$1.15

Balance Sheet

The company has $46.03 million in cash and $693,000 in debt, with a net cash position of $45.34 million or $0.80 per share.

Cash & Cash Equivalents	46.03M
Total Debt	693,000
Net Cash	45.34M
Net Cash Per Share	$0.80
Equity (Book Value)	42.62M
Book Value Per Share	0.68
Working Capital	37.98M

Cash Flow

In the last 12 months, operating cash flow was -$57.25 million and capital expenditures -$353,000, giving a free cash flow of -$57.61 million.

Operating Cash Flow	-57.25M
Capital Expenditures	-353,000
Depreciation & Amortization	695,000
Net Borrowing	n/a
Free Cash Flow	-57.61M
FCF Per Share	-$1.02

Margins

Gross Margin	100.00%
Operating Margin	-28,426.61%
Pretax Margin	-27,645.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.24%
Shareholder Yield	-1.24%
Earnings Yield	-47.33%
FCF Yield	-42.20%

Analyst Forecast

The average price target for CNTB is $7.07, which is 192.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.07
Price Target Difference	192.15%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	193.49%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1